EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

RNA Modifications in Osteoarthritis: Epitranscriptomic Insights into Pathogenesis and Therapeutic Targets

Shabnam Radbakhsh, Mehdi Najar iD, Makram Merimi, Mohamed Benderdour, Julio C Fernandes, Johanne Martel-Pelletier iD, Jean-Pierre Pelletier iD, Hassan Fahmi

International Journal of Molecular Sciences · 21.05.2025 · 26 (10) · 4955

DOI: 10.3390/ijms26104955 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.05.2025. Verfasst von Shabnam Radbakhsh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Osteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Montreal, QC H2X 0A9, Canada. Hauptthemen laut MEDLINE: Osteoarthritis, RNA Processing, Post-Transcriptional, Epigenesis, Genetic, Transcriptome. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research CIHR, La Chaire en Arthrose de l’Université de Montréal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a chronic joint disorder characterized by progressive degeneration of articular cartilage, pain, synovial inflammation, and bone remodeling. Post-transcriptional RNA modifications, known as epitranscriptome, are a group of biochemical alterations in the primary RNA transcript that might influence RNA structure, stability, and function. Different kinds of RNA modifications have been recognized, such as methylation, acetylation, pseudouridylation, and phosphorylation. N6-methyladenosine (m6A), 5-methylcytosine (m5C), N7-methylguanosine (m7G), 2′-O-ribose methylation (2′-O-Me), and pseudouridylation (Ψ) are the most prevalent RNA modifications. Recent studies have shown that disruption in these modifications can interfere with gene expression and protein function. Here, we will review all types of RNA modifications and how they contribute to the onset and progression of OA. To the best of our knowledge, this is the first review comprehensively addressing all epitranscriptomic modifications in OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisRNA Processing, Post-TranscriptionalEpigenesis, GeneticTranscriptomeRNAHumansAnimalsMethylation

Stichwörter der Autor:innen

2′-O-ribose methylation5-methylcytosineN6-methyladenosineN7-methylguanosineRNA modificationepitranscriptomicsinflammationosteoarthritis

Substanzen

RNA

Autor:innen und Institutionen

  • Osteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Montreal, QC H2X 0A9, Canada.

ORCID-Profile: Mehdi Najar, Johanne Martel-Pelletier, Jean-Pierre Pelletier

Förderung

  • Canadian Institutes of Health Research CIHR
  • La Chaire en Arthrose de l’Université de Montréal

Zitieren

APA

Radbakhsh, S., Najar, M., Merimi, M., Benderdour, M., Fernandes, J. C., Martel-Pelletier, J., Pelletier, J. P., & Fahmi, H. (2025). RNA Modifications in Osteoarthritis: Epitranscriptomic Insights into Pathogenesis and Therapeutic Targets. International Journal of Molecular Sciences, 26(10), 4955. https://doi.org/10.3390/ijms26104955

Vancouver

Radbakhsh S, Najar M, Merimi M, Benderdour M, Fernandes JC, Martel-Pelletier J, et al. RNA Modifications in Osteoarthritis: Epitranscriptomic Insights into Pathogenesis and Therapeutic Targets. International Journal of Molecular Sciences. 2025;26(10):4955. doi:10.3390/ijms26104955

BibTeX
@article{Radbakhsh2025,
  author = {Radbakhsh, Shabnam and Najar, Mehdi and Merimi, Makram and Benderdour, Mohamed and Fernandes, Julio C and Martel-Pelletier, Johanne and Pelletier, Jean-Pierre and Fahmi, Hassan},
  title = {RNA Modifications in Osteoarthritis: Epitranscriptomic Insights into Pathogenesis and Therapeutic Targets},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {10},
  pages = {4955},
  doi = {10.3390/ijms26104955}
}
Kostenlos starten →